ЭНДОВАСКУЛЯРНАЯ ОККЛЮЗИЯ УШКА ЛЕВОГО ПРЕДСЕРДИЯ УСТРОЙСТВОМ WATCHMAN КАК АЛЬТЕРНАТИВНЫЙ ПОДХОД К ПРОФИЛАКТИКЕ ТРОМБОЭМБОЛИЧЕСКИХ ОСЛОЖНЕНИЙ У ПАЦИЕНТОВ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ

1. Connolly SJ, Ezekowitz MD, Yusuf S et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med, 2009; 361:1139–51.

2. Manesh RP, Kenneth WM, Jyotsna Garg MS et al. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation. N Engl J Med, 2011; 365:883–91.

3. Granger CB, Alexander JH, McMurray JJ et al. Apixaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med, 2011;365:981–92.

4. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. The Annals of Thoracic Surgery, 1996; 61:755–9.

5. Кропачева Е. С., Заграй А. А., Быкова Е. С. и соавт. Случай восстановления синусового ритма у больного мерцательной аритмией после лизиса тромбов в левом предсердии и его ушке на фоне длительной терапии непрямыми антикоагулянтами. Ангиология и сосудистая хирургия, 2003;9:122–4.

6. WATCHMAN® Left Atrial Appendage Closure System. A Proven Device Alternative To Warfarin. Презентация на сайте фирмы-производителя устройства Watchman Boston Scientific. http://www.bostonscientific.com/watchman-eu/assets/pdf/WATCHMAN_PPT_Update.pdf.

7. Sick PB, Schuler G, Hauptmann KE et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol, 2007; 49: 1490–5.

8. Reddy V, Doshi S, Sievert H et al. Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial. Circulation, 127 (6):720–9.

9. Reddy VY, Neuzil P, Sick P, Sievert H. Minimizing the Risk for Pericardial Effusion/Tamponade During LA Appendage Closure Using a Next-Generation Watchman LAA Closure Device (Preliminary Results of the European EVOLVE Registry). Circulation, 2011; 124: A16825.

10. Möbius-Winkler S, Sandri M, Mangner N et al. The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation. J. Vis. Exp. (60), e3671, doi:10.3791/3671 (2012).

11. Reddy VY, Holmes D, Doshi SK et al. Safety of Percutaneous Left Atrial Appendage Closure Results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry. Circulation, 2011;123:417–24.

12. Reddy VY, Möbius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, Sick P, Sievert H. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). J Am Coll Cardiol, 2013; 61 (25):2551–6.

13. Reddy VY. Long term results of PROTECT AF: The mortality effects of left atrial appendage closure versus warfarin for stroke prophylaxis in AF. Presented at: Heart Rhythm Society 34th Annual Scientific Sessions; May 9, 2013; Denver, CO.

14. PREVAIL Study. Презентация на сайте фирмы-производителя устройства Watchman Boston Scientific. http://www.bostonscientific.com/watchmaneu/clinical-data/prevail-clinical-study.html

15. http://www.medpagetoday.com/upload/2013/3/9/PREVAIL.pdf

16. http://clinicaltrials.gov/show/NCT01760291

17. Connolly SJ, Eikelboom J, Campbell J et al. Apixaban in Patients with Atrial Fibrillation. N Engl J Med, 2011; 364:806–17.

18. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. European Heart Journal, 2012; 33:2719–47.

19. Swaans MJ, Alipour A, Rensing BJ et al. Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation. J. Vis. Exp. (72), e3818, doi:10.3791/3818 (2013).

20. Neuzil P. New preventive strategies: drugs and devices. Доклад на Европейском конгрессе кардиологов 2011 г. http://spo.escardio.org/eslides/view.aspx?eevtid=48&fp=1047

21. Coherex Medical Expands Portfolio with New Medical Device; New Heart Implant Treats Patients at Risk for Stroke. Пресс-релиз устройства WaveCrest. http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6487345&lang=en

22. Syed TM, Halperin JL. Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges. Nature Clinical Practice Cardiovascular Medicine, 2007;4: 428–35.

23. St. Jude Medical Receives CE Mark of Next- Generation Cardiac Device for Stroke Prevention. Пресс-релиз нового поколения устройства http://www.businesswire.com/multimedia/home/20130118005023/en/